ArticleInternational journal of chronic obstructive pulmonary disease2026
Interventions Evaluated to Improve Inhaler Adherence in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inhalation therapy is central for chronic obstructive pulmonary disease (COPD) management. However, poor inhaler adherence is associated with increased mortality, decreased quality of life, and increased costs. Existing interventions, particularly their design and delivery across urban and rural settings, have not been comprehensively mapped. Objective: To map the available interventions evaluated to improve inhaler adherence among patients with COPD and characterize their components, delivery approaches, reported outcomes, and variation across urban and rural settings. Methods: Following the Arksey and O'Malley framework, nine databases were searched from inception to March 22, 2026, including PubMed, Cochrane Library, Embase, Medline, Web of Science, CNKI, WanFang Data, CBM, and CQVIP. Two researchers independently screened the literature, extracted data, and synthesized findings. Results: The 24 included studies were from seven countries (19 randomized controlled trials, 2 quasi-experimental studies, 1 prospective cohort study, and 2 pre-post studies); 16 were published in Chinese and 8 in English. Six categories were identified according to the primary intervention component: education-focused (n=8), behaviour-focused (n=4), inhaler technique-focused (n=4), multicomponent (n=3), transitional care-focused (n=4), and reminder-focused interventions (n=1). Five studies used digital delivery, including videoconferencing, telemedicine, SMS, a gamified website, and a WeChat mini-program. Most studies reported improved inhaler adherence, while one found no statistically significant difference. Twenty-two studies were conducted in urban settings; only two Chinese studies targeted rural populations, both used transitional care with face-to-face education, telephone follow-up, and family involvement. Conclusion: The combined evidence suggests that interventions were diverse and predominantly in urban settings. Theory-informed design, ongoing follow-up, technique reassessment, digital support, and caregiver involvement were frequently identified across interventions reporting improved adherence. However, heterogeneity in intervention characteristics and adherence measures limited comparability, while evidence from rural populations remained scarce. Future research should consider longer follow-up and digital technologies to deliver personalized, sustainable interventions, particularly in rural settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.